Biolumina
Network-owned
Address
1285 Avenue of the Americas, 6th Floor
New York, New York 10019
Web Address
Year Founded
2008
Parent Company
Omnicom Group
Web Address
Full-time Employees
250
Number of Clients
7
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
1
Locations
New York, NY
Executives & Senior Management
Kirsten Kantak
President and Chief Executive Officer
Diane Iler-Smith
Chief Creative Officer
Brenda Aske
EVP, Managing Partner, Strategy
Senior Management
Kirsten A. Kantak
President and Chief Executive Officer
Diane Iler-Smith
Chief Creative Officer
Brenda Aske, RPh
EVP, Managing Partner, Strategy
David Cherry
SVP, Director of Customer Experience
Jenna Goscienski
EVP, Managing Partner, Operations
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
Direct Marketing
Med-ed
Med-Tech
Data/Analytics
Digital
New Services
No
Client Roster
Novartis - Kisqali
AstraZeneca - Tagrisso
AstraZeneca - Imfinzi
AstraZeneca - IO Pipeline
Pfizer - Braftovi + Mektovi
Pierre Fabre - Braftovi + Mektovi
Janssen and Legend - Cilta-cel
Janssen - Erleada
Janssen - Zytiga + Niraparib
Janssen - Prostate Franchise
Janssen - Teclistamab
Janssen - Talquetamab
Seagen - Tukysa Celldex Therapeutics
CDX-0159
BeiGene - Brukinsa
Growth
2021 Growth from Existing Clients
93%
2021 Growth from New Clients
7%
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Managing growth
Payer-related challenges
Pricing-related issues
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Procurement-related issues
Shrinking pharma budgets
Further diversification of services
Competition from consultancies and other non-traditional organizations
Pandemic-related disruptions
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Ongoing fallout from pandemic
Creative Samples
